Concise review: modeling central nervous system diseases using induced pluripotent stem cells.
Xianmin Zeng1, Joshua G Hunsberger2, Anton Simeonov2
1XCell Science Inc., Novato, California, USA; Buck Institute for Research on Aging, Novato, California, USA; Laboratory of Stem Cell Biology, NIH Center for Regenerative Medicine, Bethesda, Maryland, USA; National Center for Advancing Translational Sciences, NIH, Bethesda, Maryland, USA; New York Stem Cell Foundation, New York, New York, USA xzeng@xcellscience.com.
Stem Cells Translational Medicine
|November 5, 2014
Summary
Induced pluripotent stem cells (iPSCs) are revolutionizing central nervous system (CNS) disease modeling. iPSC-based screens offer efficient, patient-specific drug discovery and personalized medicine approaches.
Area of Science:
- Biotechnology
- Stem Cell Research
- Neuroscience
Background:
- Induced pluripotent stem cells (iPSCs) offer a novel platform for studying development and genetic mutations.
- Primary cell screening limitations necessitate advanced models for complex diseases.
- Central nervous system (CNS) disease modeling benefits significantly from iPSC technology.
Purpose of the Study:
- To review the paradigm shift iPSCs represent for CNS disease modeling.
- To highlight the development of biologically relevant CNS disease models for pharmaceutical screening.
- To showcase the potential of iPSC-based screens in revolutionizing drug discovery and personalized medicine.
Main Methods:
- Review of current literature and ongoing research in iPSC applications for CNS diseases.
- Analysis of strategies to overcome limitations of primary cell screening.
- Exploration of iPSC-based screening assay development for pharmaceutical use.
Main Results:
- iPSCs provide a powerful tool for understanding disease mechanisms and identifying genetic influences.
- Development of advanced iPSC-based models leads to more biologically relevant screening assays.
- Successful examples of iPSC screens demonstrate their utility in drug discovery.
Conclusions:
- iPSC-based screens enable efficient, disease-specific processes, moving beyond trial-and-error.
- Strategic development and resource sharing can accelerate advancements in the field.
- iPSC technology paves the way for sensitive diagnostics, patient-specific therapies, and personalized medicine.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
01:06Induced Pluripotent Stem Cells
4.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.7K
01:13Induced Pluripotent Stem Cells
22.8K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.8K
01:13Induced Pluripotent Stem Cells
3.4K
3.4K
01:22iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K